Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetics and Safety Between DWJ1421 and DWC201903 in Healthy Male Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Between 19 aged and 45 aged in healthy male adult~* Body weight more than 50kg~* Body Mass Index more than 18.0 and under 27.0~Exclusion Criteria:~* Those who have clinical significant liver, kidney, digestive system, respiratory, endocrine, nervous system, hematology and oncology, cardiovascular, urinary diseae or past history~* Those who have a gastrointestinal disease history that can effect drug absorption or surgery~* Those who have hypersensitivity reaction or clinically significant hypersensitivity reaction in the history of Investigational product

- Gender: MALE
- Minimum Age: 19 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- A (RT) (Type: EXPERIMENTAL): Period 1 : Reference drug (DWC201903) Period 2 : Test durg(DWJ1421)
- B (TR) (Type: EXPERIMENTAL): Period 1 : Test durg(DWJ1421) Period 2 : Reference drug (DWC201903)

Based on this trial design, predict the completion outcome and termination type (if applicable).